![NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/da/0a/4455260/Fiasp.png)
NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News
![Insulin pen Novo Nordisk Pen needles Diabetes mellitus, others, diabetes Mellitus, blood Sugar, ручка png | PNGWing Insulin pen Novo Nordisk Pen needles Diabetes mellitus, others, diabetes Mellitus, blood Sugar, ручка png | PNGWing](https://w7.pngwing.com/pngs/879/443/png-transparent-insulin-pen-novo-nordisk-pen-needles-diabetes-mellitus-others-diabetes-mellitus-blood-sugar-%D1%80%D1%83%D1%87%D0%BA%D0%B0.png)
Insulin pen Novo Nordisk Pen needles Diabetes mellitus, others, diabetes Mellitus, blood Sugar, ручка png | PNGWing
![Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD](https://cf.easd.org/data/easd/data/talks/1059_718772_1/Slide1.jpg)
Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD
![Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots](https://pharmashots.com/wp-content/uploads/2019/10/Fiasp-850x560.jpg)